Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery (QUOTABL)
|ClinicalTrials.gov Identifier: NCT03233607|
Recruitment Status : Completed
First Posted : July 28, 2017
Last Update Posted : April 24, 2019
|Condition or disease||Intervention/treatment|
|Hemorrhage, Postpartum||Procedure: Blood Draw|
Postpartum hemorrhage is a leading cause of maternal mortality and morbidity worldwide. Early intervention is dependent on care providers ability to accurately estimate ongoing blood loss. Studies in the past have shown that obstetricians and midwives tend to overestimate blood loss when the lost volumes are small while tend to underestimate by as much as 40 to 50 percent when a large volume of blood is lost.
Multiple studies have shown that routine hemoglobin assessment in postpartum patients after uneventful delivery either vaginal or via cesarean section, is not necessary. This leads to increased cost of care without any added benefit and causes inconvenience to the patients. However knowing how imprecise blood loss estimation can be it is reasonable to screen women for anemia prior to discharge.
|Study Type :||Observational|
|Actual Enrollment :||100 participants|
|Official Title:||Optimal Time for Postpartum Hemoglobin Assessment and Its Correlation With Estimated Blood Loss (EBL)/Quantitative Blood Loss (QBL)|
|Actual Study Start Date :||March 20, 2018|
|Actual Primary Completion Date :||January 4, 2019|
|Actual Study Completion Date :||April 23, 2019|
Includes antepartum patients receiving prenatal care at the Broadway Practice who plan to deliver at Allen Hospital in New York City (NYC). On postpartum day 1 and day 2, a sample of blood will be drawn in the morning for hemoglobin and hematocrit estimation.
Procedure: Blood Draw
On postpartum day 1 and day 2, a sample of blood will be drawn in the morning for hemoglobin and hematocrit estimation.
- Change in maternal hemoglobin [ Time Frame: Day 1 and Day 2 ]Maternal hemoglobin will be measured on postpartum day 1 to day 2
- Correlation of maternal hemoglobin to EBL [ Time Frame: Up to 2 days after delivery ]Maternal hemoglobin will be measured to assess correlation to visually estimated blood loss
- Correlation of maternal hemoglobin to QBL [ Time Frame: Up to 2 days after delivery ]Maternal hemoglobin will be measured to assess correlation to quantified blood loss
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03233607
|United States, New York|
|Columbia University Irving Medical Center|
|New York, New York, United States, 10032|
|Principal Investigator:||Rachana Gavara, MD||Columbia University|